RNA Virus Infections clinical trials at UCLA
1 in progress, 0 open to eligible people
Sorry, accepting new patients by invitation only
This randomized controlled trial will test whether a recently developed community-based intergenerational mentoring program known as Generation Xchange (GenX) can enhance antiviral resistance in older African-American women and men in a low-SES urban community. Additional studies will identify the biological processes that promote resistance to respiratory virus infections and viral disease in older African-American women and men.
Los Angeles, California
Our lead scientists for RNA Virus Infections research studies include Steve Cole, Ph.D..